SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001326190-23-000040
Filing Date
2023-09-28
Accepted
2023-09-28 16:55:33
Documents
13
Period of Report
2023-09-28
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K alt-20230928x8k.htm   iXBRL 8-K 89525
  Complete submission text file 0001326190-23-000040.txt   304011

Data Files

Seq Description Document Type Size
2 EX-101.SCH alt-20230928.xsd EX-101.SCH 3559
3 EX-101.LAB alt-20230928_lab.xml EX-101.LAB 632
4 EX-101.PRE alt-20230928_pre.xml EX-101.PRE 10459
7 EXTRACTED XBRL INSTANCE DOCUMENT alt-20230928x8k_htm.xml XML 4868
Mailing Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878
Business Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878 2406541450
Altimmune, Inc. (Filer) CIK: 0001326190 (see all company filings)

IRS No.: 202726770 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32587 | Film No.: 231290581
SIC: 2834 Pharmaceutical Preparations